Literature DB >> 15213116

A limited antigen-specific cellular response is sufficient for the early control of Mycobacterium tuberculosis in the lung but is insufficient for long-term survival.

Joanne Turner1, Karen M Dobos, Marc A Keen, Anthony A Frank, Stefan Ehlers, Ian M Orme, John T Belisle, Andrea M Cooper.   

Abstract

Mice that were transgenic for a T-cell receptor (TCR) specific for ovalbumin peptide(323-339) (DO11.10) were able to survive an infection with Mycobacterium tuberculosis for approximately 80 days. This limited early control of infection was associated with gamma interferon production, inducible nitric oxide synthase expression within the lung, and an influx of clonotypic lymphocytes. The control of M. tuberculosis was lost in DO11.10 mice bred in a rag mutant background, demonstrating that the immune responsiveness was recombinase dependent and likely to be associated with the expression of an alternative alpha TCR by DO11.10 mice. A characterization of the antigen specificity in DO11.10 TCR transgenic mice demonstrated that the specificity was limited and dominated by the 26-kDa (Rv1411c) lipoprotein of M. tuberculosis. This study identifies this lipoprotein as an important and potent inducer of protective T cells within the lungs of mice infected with M. tuberculosis and therefore as a possible target for vaccination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213116      PMCID: PMC427451          DOI: 10.1128/IAI.72.7.3759-3768.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections.

Authors:  G Cattoretti; S Pileri; C Parravicini; M H Becker; S Poggi; C Bifulco; G Key; L D'Amato; E Sabattini; E Feudale
Journal:  J Pathol       Date:  1993-10       Impact factor: 7.996

2.  An improved procedure for protein staining in polyacrylamide gels with a new type of Coomassie Brilliant Blue.

Authors:  W Diezel; G Kopperschläger; E Hofmann
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity.

Authors:  J H Morrissey
Journal:  Anal Biochem       Date:  1981-11-01       Impact factor: 3.365

5.  The major native proteins of the leprosy bacillus.

Authors:  S W Hunter; B Rivoire; V Mehra; B R Bloom; P J Brennan
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

6.  Characterization of the major membrane protein of virulent Mycobacterium tuberculosis.

Authors:  B Y Lee; S A Hefta; P J Brennan
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

7.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.

Authors:  K M Murphy; A B Heimberger; D Y Loh
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

8.  Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis.

Authors:  K Takayama; H K Schnoes; E L Armstrong; R W Boyle
Journal:  J Lipid Res       Date:  1975-07       Impact factor: 5.922

9.  The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection.

Authors:  Avi-Hai Hovav; Jacob Mullerad; Liuba Davidovitch; Yolanta Fishman; Fabiana Bigi; Angel Cataldi; Herve Bercovier
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells.

Authors:  Amy S Heinzel; Jeff E Grotzke; Rebecca A Lines; Deborah A Lewinsohn; Andria L McNabb; Daniel N Streblow; Veronique M Braud; Heather J Grieser; John T Belisle; David M Lewinsohn
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more
  10 in total

1.  Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation.

Authors:  Peter A Sieling; Preston J Hill; Karen M Dobos; Kerry Brookman; Andrew M Kuhlman; Mario Fabri; Stephan R Krutzik; Thomas H Rea; Darragh G Heaslip; John T Belisle; Robert L Modlin
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 2.  IL-23 and IL-17 in tuberculosis.

Authors:  Shabaana A Khader; Andrea M Cooper
Journal:  Cytokine       Date:  2008-01-22       Impact factor: 3.861

3.  A Toll-like receptor-2-directed fusion protein vaccine against tuberculosis.

Authors:  Baolin Wang; Marcela Henao-Tamayo; Marisa Harton; Diane Ordway; Crystal Shanley; Randall J Basaraba; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2007-07

4.  ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.

Authors:  Andreas Kupz; Ulrike Zedler; Manuela Stäber; Carolina Perdomo; Anca Dorhoi; Roland Brosch; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

5.  Purification and characterization of mycobacterial phospholipase A: an activity associated with mycobacterial cutinase.

Authors:  Sarah K Parker; Kathryn M Curtin; Michael L Vasil
Journal:  J Bacteriol       Date:  2007-04-06       Impact factor: 3.490

Review 6.  The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis.

Authors:  Andrea M Cooper; Shabaana A Khader
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

7.  Proteomic definition of the cell wall of Mycobacterium tuberculosis.

Authors:  Lisa M Wolfe; Spencer B Mahaffey; Nicole A Kruh; Karen M Dobos
Journal:  J Proteome Res       Date:  2010-09-29       Impact factor: 4.466

8.  A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis.

Authors:  Antoine Tanne; Bo Ma; Frédéric Boudou; Ludovic Tailleux; Hélène Botella; Edgar Badell; Florence Levillain; Maureen E Taylor; Kurt Drickamer; Jérome Nigou; Karen M Dobos; Germain Puzo; Dietmar Vestweber; Martin K Wild; Marie Marcinko; Peter Sobieszczuk; Lauren Stewart; Daniel Lebus; Brigitte Gicquel; Olivier Neyrolles
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

9.  Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses.

Authors:  Anat Zvi; Naomi Ariel; John Fulkerson; Jerald C Sadoff; Avigdor Shafferman
Journal:  BMC Med Genomics       Date:  2008-05-28       Impact factor: 3.063

10.  Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2.

Authors:  Oscar Rosas Mejia; Erin S Gloag; Jianying Li; Marisa Ruane-Foster; Tiffany A Claeys; Daniela Farkas; Shu-Hua Wang; Laszlo Farkas; Gang Xin; Richard T Robinson
Journal:  PLoS Pathog       Date:  2022-03-24       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.